PUMA BIOTECHNOLOGY, INC. 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jun 14, 2017
Insider Transaction Report
Form 4
ZAVRL FRANK
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-06-12+7,604→ 7,604 totalExercise: $79.20Exp: 2027-06-11→ Common Stock (7,604 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.